Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung Cancer in the Republic of Ireland.
Keogh RJ, Barr MP, Keogh A, McMahon D, Baird AM, Cotter S, Breen D, Fitzmaurice GJ, Fitzpatrick D, O'Brien C, Finn SP, Naidoo J. Keogh RJ, et al. Among authors: naidoo j. J Thorac Oncol. 2023 Jul;18(7):851-857. doi: 10.1016/j.jtho.2023.03.027. J Thorac Oncol. 2023. PMID: 37348994 No abstract available.
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J. Suresh K, et al. Among authors: naidoo j. J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26. J Thorac Oncol. 2018. PMID: 30267842 Free article.
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.
Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J. Suresh K, et al. Among authors: naidoo j. J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30. J Thorac Oncol. 2019. PMID: 30503891 Free article.
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ. Faivre-Finn C, et al. Among authors: naidoo j. J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19. J Thorac Oncol. 2021. PMID: 33476803 Free article. Clinical Trial.
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW Jr, Diehn M, Han SS, Wakelee HA. Aredo JV, et al. Among authors: naidoo j. J Thorac Oncol. 2021 Jun;16(6):1030-1041. doi: 10.1016/j.jtho.2021.01.1628. Epub 2021 Feb 12. J Thorac Oncol. 2021. PMID: 33588109 Free article.
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel.
Ryan DJ, Toomey S, Smyth R, Madden SF, Workman J, Cummins R, Sheehan K, Fay J, Naidoo J, Breathnach OS, Morris PG, Grogan L, O'Brien ME, Sulaiman I, Hennessy BT, Morgan RK. Ryan DJ, et al. Among authors: naidoo j. Lung Cancer. 2022 Jun;168:67-73. doi: 10.1016/j.lungcan.2022.04.013. Epub 2022 May 4. Lung Cancer. 2022. PMID: 35526313
PACIFIC in the Real World.
O'Leary C, Naidoo J. O'Leary C, et al. Among authors: naidoo j. J Thorac Oncol. 2023 Feb;18(2):133-135. doi: 10.1016/j.jtho.2022.11.015. J Thorac Oncol. 2023. PMID: 36682838 Free article. No abstract available.
306 results